A study to see the effect of Bilvadi Yog in Abnormal Uterine bleeding.
Phase 3
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2024/08/071940
- Lead Sponsor
- Dr Shruti Shivaji Zendage
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients complaining symptoms of Asrigdara such as excessive and prolonged uterine bleeding with PBAC score is greater than or equal to 150.
2.Female patients with age group 18 to 50 years.
Exclusion Criteria
1.Patients with Systemic Hemorrhagic Disorders.
2.Patients with Structural abnormalities like Uterine Polyps, Uterine Erosions, Uterine Fibroids, Ovarian mass, Malignancy of Uterus or Cervix, etc.
3.Postdelivery bleeding, Post MTP bleeding, Post D and C bleeding.
4.Patients with Intra Uterine Contraceptive Device.
5.Injuries to Reproductive tract.
6.Systemic disorders like, Diabetes Mellitus, Severe anemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Sign and Symptoms of Asrugdara after Giving Bilvadi YogaTimepoint: At baseline and 7 days Reduction in Sign and Symptoms of Asrugdara after Giving Bilvadi Yoga
- Secondary Outcome Measures
Name Time Method where the trial group stands in comparison with control groupTimepoint: 18 months